"Timolol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A beta-adrenergic antagonist similar in action to PROPRANOLOL. The levo-isomer is the more active. Timolol has been proposed as an antihypertensive, antiarrhythmic, antiangina, and antiglaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor.
| Descriptor ID |
D013999
|
| MeSH Number(s) |
D02.033.100.624.915 D02.033.755.624.915 D02.092.063.624.915 D02.886.675.867.768 D03.383.129.708.867.768 D03.383.533.640.775
|
| Concept/Terms |
Timolol- Timolol
- (S)-1-((1,1-Dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadazol-3-yl)oxy)-2-propanol
- Timolol Hemihydrate
- Hemihydrate, Timolol
|
Below are MeSH descriptors whose meaning is more general than "Timolol".
Below are MeSH descriptors whose meaning is more specific than "Timolol".
This graph shows the total number of publications written about "Timolol" by people in this website by year, and whether "Timolol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 0 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Timolol" by people in Profiles.
-
Difficult decisions, filtration surgery, and the heartbreak of the numerator. J Cataract Refract Surg. 2024 01 01; 50(1):97-103.
-
A 3-month randomized controlled trial of bimatoprost (LUMIGAN) versus combined timolol and dorzolamide (Cosopt) in patients with glaucoma or ocular hypertension. Ophthalmology. 2003 Dec; 110(12):2362-8.
-
Topical timolol and serum lipoproteins. Br J Ophthalmol. 1992 Mar; 76(3):191-2.
-
Topical timolol decreases plasma high-density lipoprotein cholesterol level. Arch Ophthalmol. 1990 Sep; 108(9):1260-3.
-
Apraclonidine hydrochloride: an evaluation of plasma concentrations, and a comparison of its intraocular pressure lowering and cardiovascular effects to timolol maleate. Trans Am Ophthalmol Soc. 1990; 88:149-59; discussion 159-62.